[Current therapy in lipid metabolism disorders].
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000628:therapy; D003920:Diabetes Mellitus / Q000628:therapy; D004035:Diet Therapy; D004041:Dietary Fats; D004809:Ephedrine / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy*; D007610:Kallikreins / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010184:Pancreatic Extracts / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D004041:Dietary Fats; D009539:Nicotinic Acids; D010184:Pancreatic Extracts; D007610:Kallikreins; D004809:Ephedrine
Die bisherige Therapie bei Fettstoffwechselstörungen.